Cyclo Therapeutics - 53 Year Dividend History | CYTH
Historical dividend payout and yield for Cyclo Therapeutics (CYTH) since 1971. The current TTM dividend payout for Cyclo Therapeutics (CYTH) as of December 20, 2024 is $0.00. The current dividend yield for Cyclo Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.001B |
|
Cyclo Therapeutics Inc. is a clinical-stage biotechnology company. It develops cyclodextrin-based products for the treatment of disease. The company's Trappsol(R) Cyclo(TM), an orphan drug designated product primarily in the United States and Europe, is in ongoing formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease. Cyclo Therapeutics Inc., formerly known as CTD Holdings Inc., is based in ALACHUA, Fla.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
